SKI Market

Indian Indices

Nifty

25,461.30 0.30
(0.00%)

Sensex

83,442.50 9.61
( 0.01%)

Bank Nifty

56,949.20 -82.70
( -0.15%)

Nifty IT

38,866.95 -299.60
( -0.76%)

Global Indices

Nasdaq

44,849.54 344.11
(0.77%)

Dow Jones

6,300.35 51.93
(0.83%)

Hang Seng

39,585.13 -225.75
(-0.57%)

Nikkei 225

8,806.53 -16.38
(-0.19%)

Forex

USD-INR

85.44 -0.20
(-0.23%)

EUR-INR

100.61 -0.32
(-0.32%)

GBP-INR

116.59 -0.52
(-0.45%)

JPY-INR

0.59 0.00
(-0.64%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

91669

INE0PLZ01012

37.7078673

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNREST

11.16

22.31

EPS(TTM)

Face Value()

Div & Yield %

4.66

Back

Shree Salasar Investments reports consolidated net profit of Rs 1.34 crore in the December 2024 quarter

Feb 15,2025

Net profit of Shree Salasar Investments reported to Rs 1.34 crore in the quarter ended December 2024. There were no net profit/loss reported during the previous quarter ended December 2023. Sales rose 498.03% to Rs 12.14 crore in the quarter ended December 2024 as against Rs 2.03 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	12.14	2.03	498
OPM %	14.50	9.85	-
PBDT	1.75	0.06	2817
PBT	1.75	0.06	2817
NP	1.34	0	0

25,461.30 0.30 (0.00%)

83,442.50 9.61 ( 0.01%)

56,949.20 -82.70 ( -0.15%)

38,866.95 -299.60 ( -0.76%)

44,849.54 344.11 (0.77%)

6,300.35 51.93 (0.83%)

39,585.13 -225.75 (-0.57%)

8,806.53 -16.38 (-0.19%)

85.44 -0.20 (-0.23%)

100.61 -0.32 (-0.32%)

116.59 -0.52 (-0.45%)

0.59 0.00 (-0.64%)